Eureka Genomics is Decision/Risk Analysis in United States that focus on infectious diseases business. Founded in 2007. They cover business area such as Provider, diagnostic service, inherit genetic trait, cancer, infectious disease, human body, various application, analysis, read, detection, foreign nucleic acid, custom design, ultra-specific signature, pathogen sub, de novo draft assembly, mapping, genome/gene.
2007
( 17 years old in 2024 )
Infectious Diseases
-
750 Alfred Nobel Drive
Suite 108
Hercules, CA 94547
United States
Private
Providerdiagnostic serviceinherit genetic traitcancerinfectious diseasehuman bodyvarious applicationanalysisreaddetectionforeign nucleic acidcustom designultra-specific signaturepathogen subde novo draft assemblymappinggenome/gene
* We use standard office opening hours in near Eureka Genomics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Eureka Genomics is Decision/Risk Analysis business from United States that founded in 2007 (17 years old in 2024), Eureka Genomics business is focusing on Infectious Diseases.
Eureka Genomics headquarter office and corporate office address is located in 750 Alfred Nobel Drive Suite 108 Hercules, CA 94547 United States.
Eureka Genomics was founded in United States.
In 2024, Eureka Genomics is currently focus on infectious diseases sector.
Above is snippet of Google Trends for "infectious diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Eureka Genomics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
